![](/img/cover-not-exists.png)
Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFN
Ho, P.-C., Meeth, K. M., Tsui, Y.-C., Srivastava, B., Bosenberg, M. W., Kaech, S. M.Volume:
74
Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-13-3461
Date:
June, 2014
File:
PDF, 4.61 MB
english, 2014